BR9815335A - Uso de antagonistas de receptor de endotelina. - Google Patents

Uso de antagonistas de receptor de endotelina.

Info

Publication number
BR9815335A
BR9815335A BR9815335-8A BR9815335A BR9815335A BR 9815335 A BR9815335 A BR 9815335A BR 9815335 A BR9815335 A BR 9815335A BR 9815335 A BR9815335 A BR 9815335A
Authority
BR
Brazil
Prior art keywords
receptor antagonists
endothelin receptor
obesity
endothelin
diseases caused
Prior art date
Application number
BR9815335-8A
Other languages
English (en)
Inventor
Klaus M Nter
Michael Kirchengast
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of BR9815335A publication Critical patent/BR9815335A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"USO DE ANTAGONISTAS DE RECEPTOR DE ENDOTELINA" O uso de antagonistas de receptor de endotelina para produzir drogas para controlar obesidade e doenças causadas por obesidade.
BR9815335-8A 1997-12-05 1998-11-21 Uso de antagonistas de receptor de endotelina. BR9815335A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754082A DE19754082A1 (de) 1997-12-05 1997-12-05 Methode zur Bekämpfung der Fettleibigkeit
PCT/EP1998/007501 WO1999029308A2 (de) 1997-12-05 1998-11-21 Methode zur bekämpfung der fettleibigkeit

Publications (1)

Publication Number Publication Date
BR9815335A true BR9815335A (pt) 2000-10-17

Family

ID=7850913

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815335-8A BR9815335A (pt) 1997-12-05 1998-11-21 Uso de antagonistas de receptor de endotelina.

Country Status (17)

Country Link
US (1) US6197780B1 (pt)
EP (1) EP1035851B1 (pt)
JP (1) JP2002512173A (pt)
KR (1) KR20010032779A (pt)
CN (1) CN1152685C (pt)
AT (1) ATE204172T1 (pt)
AU (1) AU751053B2 (pt)
BR (1) BR9815335A (pt)
CA (1) CA2311423C (pt)
CZ (1) CZ300442B6 (pt)
DE (2) DE19754082A1 (pt)
ES (1) ES2162493T3 (pt)
HK (1) HK1037141A1 (pt)
HU (1) HUP0100171A3 (pt)
NO (2) NO324694B1 (pt)
RU (1) RU2292891C2 (pt)
WO (1) WO1999029308A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533023B4 (de) 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
US20050175667A1 (en) * 2004-02-10 2005-08-11 Wenda Carlyle Use of endothelin antagonists to prevent restenosis
CA2697057A1 (en) 2007-08-22 2009-02-26 Gilead Colorado, Inc. Therapy for complications of diabetes
LT3329919T (lt) * 2011-11-11 2020-02-10 Gilead Apollo, Llc Acc inhibitoriai ir jų panaudojimas
EA201700155A1 (ru) * 2014-10-20 2017-10-31 Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" Фармацевтическая композиция для лечения туберкулеза
AR106472A1 (es) 2015-10-26 2018-01-17 Gilead Apollo Llc Inhibidores de acc y usos de los mismos
CA3004796C (en) 2015-11-25 2023-11-14 Gilead Apollo, Llc Pyrazole acc inhibitors and uses thereof
MX2018006285A (es) 2015-11-25 2018-09-07 Gilead Apollo Llc Composiciones fungicidas que contienen derivados de 2,4-dioxido-1,4-dihidrotieno[2,3-d] pirimidina.
JP2018536660A (ja) 2015-11-25 2018-12-13 ギリアド アポロ， エルエルシー エステルａｃｃ阻害剤およびその使用
PL3380479T3 (pl) 2015-11-25 2023-05-08 Gilead Apollo, Llc Triazolowe inhibitory acc i ich zastosowania
BR112018067408A2 (pt) 2016-03-02 2018-12-26 Gilead Apollo Llc formas sólidas de um inibidor de acc de tienopirimidinadiona e métodos para a produção das mesmas
WO2018183193A1 (en) 2017-03-28 2018-10-04 Gilead Sciences, Inc. Therapeutic combinations for treating liver diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950704314A (ko) 1992-12-01 1995-11-17 가와노 다케히코 1,8-나프티리딘-2-온 유도체 및 그 사용 방법(1,8-naphthyridin-2-one derivative and use thereof)
WO1997008169A1 (en) 1995-08-24 1997-03-06 Warner-Lambert Company Furanone endothelin antagonists
JP3116347B2 (ja) * 1996-11-13 2000-12-11 田辺製薬株式会社 医薬組成物

Also Published As

Publication number Publication date
KR20010032779A (ko) 2001-04-25
EP1035851A2 (de) 2000-09-20
AU2153599A (en) 1999-06-28
HUP0100171A3 (en) 2003-10-28
CN1152685C (zh) 2004-06-09
ATE204172T1 (de) 2001-09-15
RU2003138080A (ru) 2005-06-10
WO1999029308A3 (de) 1999-09-30
NO20002777D0 (no) 2000-05-30
ES2162493T3 (es) 2001-12-16
CN1301162A (zh) 2001-06-27
EP1035851B1 (de) 2001-08-16
CZ300442B6 (cs) 2009-05-20
NO20002777L (no) 2000-06-02
AU751053B2 (en) 2002-08-08
JP2002512173A (ja) 2002-04-23
NO20074419L (no) 2000-06-02
WO1999029308A2 (de) 1999-06-17
HK1037141A1 (en) 2002-02-01
US6197780B1 (en) 2001-03-06
CA2311423A1 (en) 1999-06-17
HUP0100171A2 (hu) 2003-02-28
CA2311423C (en) 2008-01-29
DE59801230D1 (de) 2001-09-20
RU2292891C2 (ru) 2007-02-10
CZ20002006A3 (cs) 2000-11-15
NO324694B1 (no) 2007-12-03
DE19754082A1 (de) 1999-06-10

Similar Documents

Publication Publication Date Title
ES2304795T3 (es) Anticuerpos agonistas para el receptor de trombopoyetina y sus usos terapeuticos.
NO20074419L (no) Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom
FI960953A0 (fi) Endoteliinireseptoriantagonisteja
FI961804A (fi) Endoteliinireseptoriantagonistit
BR9612779A (pt) Antagonistas ao receptor de il-8
ATE360032T1 (de) Cystein-reiche rezeptoren-train
PT911340E (pt) Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos
BR9609035A (pt) Anticorpos monoclonais de macaco específicos para formas primatizadas B7.1 e/ou B&.2 humanas composições farmacéuticas
EE9900304A (et) Tsentraalse kannabioidretseptori antagonistide kasutamine apetentsi reguleerimiseks
BR0110968A (pt) Antagonistas dos receptores de il-8
HUP0001931A2 (hu) Kémiai vegyületek
ATE213156T1 (de) Endothelin-rezeptor-antagonisten
BR9909486A (pt) Compostos calcilìticos
BR0213684A (pt) Uso de antagonistas do receptor de endotelina para o tratamento de doenças tumorìgenas
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
ES2171196T3 (es) Uso de antagonistas del receptor cck-b para el tratamiento de trastornos del sueño.
MX9606179A (es) Agonistas y antagonistas de los receptores del acido acetilcolina nicotinico de insectos para el control de endoparasitos.
BR9804749A (pt) Tratamento de purido.
ITTO960496A0 (it) Modificatione di farmaci polipeptidici per accrescere il flusso per e-lettrotrasporto.
NO972612D0 (no) Pyridazoner som endotelinreseptorantagonister
DE69636597D1 (de) Endothelin rezeptor antagonisten
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
FR2791974B1 (fr) Composition ceramique piezo-electrique et vibreur et actuateur l'utilisant
ES2152315T3 (es) Xamoneline tartrato.
DE69203803D1 (de) Abstandselement als zusatz zu dübelverankerungsvorrichtungen für wandbekleidungsplatten.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B25A Requested transfer of rights approved

Free format text: ABBOTT GMBH (DE)

B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM OS ARTIGOS 8O, 24 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.